| Name | 8-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-1,4-benzoxazin-3-one |
|---|---|
| Synonyms |
2H-1,4-BENZOXAZIN-3(4H)-ONE,8-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)
2H-1,4-Benzoxazin-3(4H)-one, 8-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- 8-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE 8-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-1,4-benzoxazin-3(4H)-one |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 449.8±45.0 °C at 760 mmHg |
| Molecular Formula | C15H20BNO4 |
| Molecular Weight | 289.135 |
| Flash Point | 225.8±28.7 °C |
| Exact Mass | 289.148529 |
| PSA | 60.28000 |
| LogP | 1.71020 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.540 |
| Storage condition | 2-8°C |
| Hazard Codes | Xn |
|---|---|
| Risk Phrases | 22-36/37/38 |
| Safety Phrases | 26-36/39 |
| HS Code | 2934999090 |
|
~%
943994-87-4 |
| Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent: WO2007/77961 A2, 2007 ; Location in patent: Page/Page column 361 ; WO 2007/077961 A2 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |